Hoth Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Topical Delivery
  • Biotechnology

Other Names/Subsidiaries

  • Hoth Therapeutics Australia
  • Novotech
See more in Biomedtracker

Latest on Hoth Therapeutics, Inc.

Scrip

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Scrip

Deal Watch: Dianthus Will Reach Public Markets Via Reverse Merger With Stalled-Out Magenta

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Newly Public Dianthus Projects Financia

Scrip

Deal Watch: Lilly Teams With Regor On Metabolic Disorders

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Doubles Down On Metabolic Disorde

Scrip

Tech Transfer Roundup: Sanofi Gets IP For Multiple Myeloma From Memorial Sloan Kettering

 
• By Joseph Haas

Sanofi Gets IP From MSKCC, Eureka Applicable In Multiple Myeloma Therapy Sanofi signed an agreement on 6 July to acquire intellectual property covering non-chimeric antigen receptor (CAR) use of a n